2Le Chevalier T,Brisgand D,Douillard JY,et al.Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer:results of a European mnuticenter trial including 612 patients[J].J Clin Oncol,1994,12(2):360
3Comella p,Frasci G,Panza N,et al.Randomized trial comparing cisplatin,gemcitabine,and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer:interim analysis of a phase Ⅲ trial of the Southern Italy Cooperative Oncology Group[J].J Clin,2000,18(7):1451
4Adjei A A, Argiris A, Murren J R. Docetaxel and iri note can alone and incombination, in the treatment of non-small cell lung cancer[J]. Semin Oncol, 1999, 26(Supp116) :32.
5Bunn PA Jr, Kelley K. New chemotherapeutic agents, prolong survival and improve quality of life in non-small cell lung cancer:a review of the literature and future directions[J]. Clin Cancer Res, 1998, 4(5):1087.
